Scott Hampton
Directed and led projects leading to over thirty 510(k), PMA, and NDA approvals in drug delivery, ophthomalogy, dental, cosmetics, emergency medicine, obstetrics, oncology, and diabetes.
Clients have included Intarcia, ElectroMedical Systems, Anteis, CIBA Vision, STAAR Surgical, Schwind Eye-Tech, Novartis, Clinton Health Initiative, Exsurco, Bill and Melinda Gates Foundation, Ophtha International, Solo Health, Glenveigh Medical, Duckworth & Kent, Helsinn Pharma, Myelotec, Norwood Eye-Care, and many other firms ranging from concept-phase startups through multinationals.
Led brand licensing for Tropic Isle Living (2023), with terms satisfactory to the owners. Starting in January 2020, well before most business leaders were considering the possibility of a pandemic: solidified and then twice re-built supply chains, establishing direct imports, and rationalizing manufacturing. This allowed the company to grow retail distribution by a factor of five. Expanded the business to include contract manufacturing and white-label. Hired great people so that a smaller team could be more deliverable.
Startups: $7.4 million raised in angel and seed rounds for USA and EU entrepreneurs.
Various complex new factory or new product line IQ/OQ/PQ/Ver/Val programs with large and small teams.
Advise boards and executives, either coaching or in reporting roles, on business growth and objectives and execution.
(CV available on request)